1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Two-stage process: pre-proposal form submitted first, then shortlisted candidates invited to full proposal. Final deadline April 20, 2026 at 23:59. Managed via FRS-FNRS on behalf of Generet Fund/King Baudouin Foundation.
"The Generet Award for Rare Diseases" is currently closed and not accepting applications.
The Generet Award for Rare Diseases is a grant from the Generet Fund, managed by the King Baudouin Foundation, that funds four-year research projects focused on rare diseases in Belgium. The award, now in its 9th year, supports internationally established investigators pursuing advances in understanding and treating conditions affecting no more than 1 in 2,000 people. Rare cancers and rare adverse drug events are not eligible.
Applicants must hold a PhD with at least 10 years of scientific seniority and be affiliated with a Belgian university, university hospital, or eligible research institute through December 31, 2030. The award totals €1,250,000: an initial €750,000 for two years, followed by €500,000 contingent on a positive midterm review. The application deadline was April 20, 2026.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Generet Award for Rare Diseases 2026 | FNRS Generet Award for Rare Diseases 2026 Research project in the field of rare diseases.
Awards & Philanthropic Funding Permanent research status (R3) and Senior research position (R4) On the initiative of the Generet Fund, managed by the King Baudouin Foundation, the prestigious Generet Award will be granted in 2026, for the 9th time in a row, to support a 4-year research project in the field of rare diseases in Belgium. The Award amounts to €1,250,000 over 4 years.
A first installation of €750,000 will be credited for 2 years. The second installation of 500,000 € will be subject to the positive evaluation of a mid-term scientific, financial and communication report. Rare diseases are considered to be life threatening or chronic conditions which affect no more than 1 person out of 2,000.
Rare cancers and rare adverse drug events research projects are not eligible for this call. Proposals will undergo a two-step application procedure encompassing a pre-proposal phase (open to all) and a full proposal phase (accessible to shortlisted applicants from the first stage). Applicants submitting a pre-proposal must fill in a administrative brief form, provide a letter of intent of max.
3 pages focusing on the scientific proof of concept of the research project and attach a relevance core bibliography and a short CV.
Applicants must be internationally established investigators, with outstanding scientific achievements and multiple seminal contributions in: the field of rare diseases common diseases, but who can demonstrate that their research will have a substantial added value for rare diseases and can accelerate research in this particular field. Applicants must have a scientific seniority of min.
PhD + 10 years at the deadline of the call (career breaks, such as maternity leave or long-time illness, not included) . Applicants must be affiliated to a Belgian University, a Belgian University Hospital or an eligible Research Institute , until December 31, 2030 and not reach the retirement age limit during the project timeframe.
Former laureates cannot reapply to the Generet Award as Principal Investigator but can be partners in other applications (at the earliest 4 years after being laureate). Eligible research project The research project must be conducted in Belgium in the field of rare diseases.
The research project should aim at a better understanding of the processes underpinning rare diseases and translating fundamental discoveries into better prevention, diagnosis or treatment for patients. Research can encompass all internships from bench to bedside. Eligible expenses encompass personnel costs, running costs and equipment.
A maximum of 10% in overheads may be applied to this amount. These overheads are included within the Prize money and are not added on top of it. Up to 30% of the Award's amount can be outsourced for supporting international or intranational expenses (personnel and running costs) including the private sector if they charge at cost price.
Opening of the call: February 16, 2026 Pre-proposals deadline: April 20, 2026 First Panel meeting: May 27, 2026 Invitation for full proposals: Following the first Panel meeting Full proposals deadline: 6 July 2026 Second Panel meeting: November 17, 2025 Start of the research: 1 January 2027 Pre-proposals, written in English, must be submitted via the online application system available on www. generetaward.
be we april 20, 2026 at the latest. The complete regulations of the Generet Award 2026 are available here . The list of the previous laureates is available here .
Questions about the Award should be addressed via email to prix@frs-fnrs. be . The complete regulations of the Generet Award 2026 are available here .
According to the current listing, eligibility includes: Minimum PhD plus 10 years scientific seniority; must be affiliated with a Belgian university, hospital, or eligible research institute through December 31, 2030; research must focus on rare diseases affecting ≤1 in 2,000 people. Confirm the full requirements in the official notice before applying.
The current listing shows €1,250,000 over 4 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was April 20, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
The Generet Award for Rare Diseases is funded by Generet Fund, managed by the King Baudouin Foundation. Verify program details on the funder's official page before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Microsoft launched Community-First Grants on September 21, 2026 — $1 million to King County nonprofits, applications through October 23, grantees notified in November. The scope is small and the geography is narrow, but the eligibility gate inverts how corporate philanthropy normally works, and the things the announcement does not specify tell you more than the things it does.
Read articleOn August 25, 2026 a Ninth Circuit panel affirmed most of a sweeping injunction against HUD, DOT, and HHS grant conditions covering roughly $14 billion. The opinion sorts conditions into four buckets — and only one of them holds up. Here is what changed for every recipient of a federal award.
Read articleOn June 8, HHS and GSA launched a new Grants Management Special Item Number — SIN 518210GM — creating a government-wide buying lane for modern, standards-compliant grants software tied to more than $1.2 trillion in annual awards. It reads like procurement plumbing. For grantees, govtech vendors, and the future of grant data interoperability, it is anything but.
Read article